Editorial Contact | Get in Touch Editorial Contact Our Story Offices Insights Support Get Started Contact Us. Connecting global perspectives through intentional dialogue. Our editorial team is ready to assist …
chnfo@suni0
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">Contact form>
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">Good News for Patients Worried About Statin Side Effects: Study Finds Most Never Happen>by chnfo@suni0by chnfo@suni0
Analysis of Statin Safety and Adverse Event Attribution A large-scale analysis published in *The Lancet* offers significant reassurance regarding the tolerability of statin therapy, finding that the vast majority of …
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">Benefits and Risks of PFO Closure by Causal Likelihood>by chnfo@suni0by chnfo@suni0
Benefits and Risks of PFO Closure by Causal Likelihood A recent meta-analysis suggests that the benefits of transcatheter PFO closure for secondary stroke prevention rely heavily on the likelihood that …
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">Test post>by chnfo@suni0by chnfo@suni0
✏️ ADMIN EDIT MODE local_hospital MedJournal dark_mode Research chevron_right Immunology Targeted Immunotherapy in Chronic Autoimmune Disorders A comprehensive analysis of novel monoclonal antibody treatments and their long-term efficacy in Phase …
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">>by chnfo@suni0by chnfo@suni0
y
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">test post>by chnfo@suni0by chnfo@suni0
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">>by chnfo@suni0by chnfo@suni0
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">First>by chnfo@suni0by chnfo@suni0
Login/Sign Up – MedResearch Pro MedResearch Pro Research Pricing About Log In Sign Up menu Welcome to MedResearch Pro Join thousands of medical professionals advancing their knowledge. Continue with Google …
- Cardiology < class="penci-entry-title entry-title grid-title penci_grid_title">First>by chnfo@suni0by chnfo@suni0
Login/Sign Up – MedResearch Pro MedResearch Pro Research Pricing About Log In Sign Up menu Welcome to MedResearch Pro Join thousands of medical professionals advancing their knowledge. Continue with Google …
- DERMATOLOGYIMMUNOLOGYRHEUMATOLOGY < class="penci-entry-title entry-title grid-title penci_grid_title">Enpatoran delivers robust skin lupus efficacy across CLE and SLE, achieving high CLASI responses and early IFN suppression in WILLOW trial>by chnfo@suni0by chnfo@suni0
The WILLOW trial reveals Enpatoran’s strong performance in mucocutaneous lupus, achieving high CLASI-50 and CLASI-70 response rates, remission milestones, and rapid IFN gene suppression in both CLE and SLE patients.
